OKYO Pharma director reports option holdings
OKYO Pharma Ltd director Bernard Denoyer filed an initial ownership report showing multiple option grants over OKYO common stock.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
3
Rhea-AI Filing Summary
OKYO Pharma Ltd director Bernard Denoyer filed an initial ownership report showing multiple option grants over OKYO common stock. The options have exercise prices ranging from $1.46 to $2.13 per share and expire between 2033 and 2035. Examples include options over 3,750 underlying shares at $1.50 expiring in 2035 and options over 3,334 underlying shares at $1.46 expiring in 2034.
Insider Trade Summary
Holdings reported, no transactions
Holdings
Insider
Denoyer Bernard
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Holding | Options | -- | -- | -- |
| Holding | Options | -- | -- | -- |
| Holding | Options | -- | -- | -- |
| Holding | Options | -- | -- | -- |
| Holding | Options | -- | -- | -- |
| Holding | Options | -- | -- | -- |
| Holding | Options | -- | -- | -- |
| Holding | Options | -- | -- | -- |
| Holding | Options | -- | -- | -- |
| Holding | Options | -- | -- | -- |
| Holding | Options | -- | -- | -- |
| Holding | Options | -- | -- | -- |
| Holding | Options | -- | -- | -- |
| Holding | Options | -- | -- | -- |
Holdings:
Options — 31,690 contracts (Direct)
Key Figures
Option exercise price: $1.50/share
Underlying shares: 3,334 shares
Option exercise price: $1.60/share
+2 more
5 metrics
Option exercise price
$1.50/share
Options over 3,750 underlying common shares expiring 2035-03-25
Underlying shares
3,334 shares
Options at $1.46 exercise price expiring 2034-03-13
Option exercise price
$1.60/share
Options over 1,205 underlying shares expiring 2035-01-29
Option exercise price
$2.13/share
Options over 770 underlying shares expiring 2033-03-14
Transaction classification
14 holding entries
Form 3 transactionSummary, all coded as holdings
Key Terms
Options, exercise price, underlying security, expiration date, +1 more
5 terms
Options financial
"security_title": "Options""
Options are contracts that give investors the right to buy or sell an asset at a specific price within a certain time frame. They function like a reservation or a ticket that allows for potential profit or protection against price changes, making them useful tools for managing investment risks or speculating on market movements.
exercise price financial
"conversion_or_exercise_price": "1.5000""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
underlying security financial
"underlying_security_title": "common stock""
expiration date financial
"expiration_date": "2035-03-25T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
transaction_type financial
"transaction_type": "holding""
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does Bernard Denoyer’s Form 3 filing for OKYO Pharma report?
The Form 3 filing reports Bernard Denoyer’s existing holdings of stock options over OKYO Pharma common shares. It lists multiple option grants with specific exercise prices, underlying share amounts, and expiration dates, establishing his baseline derivative position as a company director.
What option exercise prices are disclosed for OKYO Pharma (OKYO) director Bernard Denoyer?
The filing shows stock options with exercise prices of $1.46, $1.50, $1.60, and $2.13 per share. Each grant is tied to a distinct set of underlying common shares and a separate expiration date between 2033 and 2035.
When do Bernard Denoyer’s reported OKYO Pharma stock options expire?
The options reported in the Form 3 expire between 2033-03-14 and 2035-03-25. Each option series lists a specific expiration date, with later-dated grants generally having exercise prices of $1.50 or $1.60 per share over OKYO common stock.
Does the OKYO Pharma Form 3 show any recent insider buying or selling by Bernard Denoyer?
The Form 3 functions as an initial ownership report and shows holdings classified as “holding” transactions. It does not identify any entries as open-market purchases or sales; it simply lists existing option positions with exercise prices, share counts, and expiration dates.
AI-generated analysis. How Rhea-AI works. Not financial advice.
